SEC Form D filing

Avenue Biosciences Holding Inc, 2026-01-28

An SEC Form D private-offering notice from Menlo Park, CA, a $8,357,349 filer-stated offering target in Biotech. Filed 2026-01-28. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Avenue Biosciences Holding Inc site↗ Verified via SEC Form D

Develops a protein engineering platform that optimizes the secretory pathway to improve therapeutic protein manufacturing, using a library of engineered signal peptides and machine learning.

Filed 2026-01-28Filed to raise $8,357,349First money in 2025-11-20Raised so far $7,440,682HQ (as filed) Menlo Park, CASector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified avenuebiosciences.com↗Named in the filing 4 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source